Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more

México Noticias Noticias

Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more
México Últimas Noticias,México Titulares
  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

These are the stocks posting the largest moves in the premarket.

A Tesla electric car is plugged into a recharging terminal at a Healthy Living Market store June 18, 2023 in South Burlington, Vermont.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

CNBC /  🏆 12. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Tesla Leads Surge in Battered Clean-Energy StocksA rally in Tesla shares is lifting beaten-down clean-energy stocks, a boon for investors and startups battered by rising rates and supply-chain disruptions
Leer más »

Tesla stock slips on downgrade, IBM shares ease on reported deal and other stocks on the moveIBM, Tesla and Novo Nordisk are some of the stocks on the move.
Leer más »

26 stunning OC aerial images that look like the alphabet26 stunning OC aerial images that look like the alphabetOrange County can look chaotic from the air, but if you look long enough, you can find patterns – like the English alphabet.
Leer más »

UBS downgrades Google-parent Alphabet, cites stiffer competition and generative A.I. headwindsThe bank downgraded the tech giant to neutral from buy, albeit with a higher $132 per share price target compared to the previous $123 forecast.
Leer más »

Moderna Asks FDA to Approve XBB COVID ShotModerna Asks FDA to Approve XBB COVID ShotModerna has applied for FDA approval of a new COVID-19 vaccine targeting the predominant strain of the virus called XBB.1.5. The company said it is prepared to roll out the shot this fall.
Leer más »

UBS upgrades Moderna to buy while cutting price targetUBS upgraded its rating on vaccine maker Moderna to buy from neutral on valuation grounds, but cut its price target to $191 from $221. “We acknowledge the...
Leer más »



Render Time: 2025-03-01 09:19:31